Skip to main content
*** NOTE: Terms of Service Updated 21 Feb 2018 ***

Researchers Urge More Transparency From FDA

  • Published: 2017-03-18 : Johns Hopkins University Bloomberg School of Public Health (jhsph.edu).
  • Synopsis: Researchers create Blueprint for Transparency to advance the development of safe and effective new products.

Main Document

Quote: "All of the Blueprint's recommendations can be implemented by FDA without new legislation from Congress, and all respect legal protections for trade secrets."

As the new administration considers the future direction of the Food and Drug Administration, a group of leading researchers has created a Blueprint for Transparency at the agency to advance the development of safe and effective new products.

The researchers include senior faculty from the Johns Hopkins Bloomberg School of Public Health, Harvard Medical School/Brigham and Women's Hospital, Yale Medical School, and Yale Law School. The project was organized by Joshua Sharfstein, MD, Professor of the Practice at the Bloomberg School.

Sharfstein and Michael Stebbins, PhD, of the Laura and John Arnold Foundation, have authored an overview of the Blueprint in JAMA, released online March 13.

The full report, Blueprint for Transparency at the U.S. Food and Drug Administration, is being released simultaneously online at http://www.jhsph.edu/blueprintFDA

"FDA is more than an agency that makes regulatory decisions," says Sharfstein, a former FDA Principal Deputy Commissioner. "It is also a repository for scientific analysis and data that, if more widely available, would improve understanding of existing therapies, the pharmaceutical pipeline and opportunities for innovative product development."

The report makes 18 recommendations in five principal areas:

All of the Blueprint's recommendations can be implemented by FDA without new legislation from Congress, and all respect legal protections for trade secrets.

"Enhancing Transparency at the U.S. Food and Drug Administration: Moving Beyond the 21st Century Cures Act" was written by Joshua M. Sharfstein and Michael Stebbins. The full Blueprint for Transparency was written by the FDA Transparency Working Group which includes Sharfstein as well as James Dabney Miller, Anna L Davis, Caleb Alexander, Brian Smith and Anam Chaudry of the Bloomberg School; Joseph S. Ross of Yale Medical School; Margaret E. McCarthy of Yale Law School; and Aaron Kesselheim of Brigham and Women's Hospital/Harvard Medical School.

The Blueprint for Transparency is supported by a grant from the Laura and John Arnold Foundation.

Similar Topics

1 : Statement From FDA Commissioner on Steps to Facilitate Efficient Generic Drug Review to Enhance Competition, Promote Access and Lower Drug Prices : U.S. FDA.
2 : FDA Permits Marketing of Device to Treat Diabetic Foot Ulcers : U.S. Food and Drug Administration.
3 : U.S. FDA Approves Gene Therapy for Treatment of Cancer and Life-threatening Diseases : U.S. Food and Drug Administration.
4 : U.S. FDA Approves Radicava (Edaravone) to Treat ALS : U.S. Food and Drug Administration.
5 : U.S. FDA Approves Ocrevus (Ocrelizumab) to Treat Multiple Sclerosis : U.S. Food and Drug Administration (FDA).
From our FDA Approvals section - Full List (63 Items)

Submit disability news, coming events, as well as assistive technology product news and reviews.


Loan Information for low income singles, families, seniors and disabled. Includes home, vehicle and personal loans.


Famous People with Disabilities - Well known people with disabilities and conditions who contributed to society.


List of awareness ribbon colors and their meaning. Also see our calendar of awareness dates.


Blood Pressure Chart - What should your blood pressure be, and information on blood group types/compatibility.





1 : Free Eye Exams to Service and Working Animals in May from Veterinary Ophthalmologists
2 : Early Childhood Education Needs to be Accessible and Affordable
3 : How the Human Brain Can Tell Our Arms and Legs Apart
4 : Protein Levels in Spinal Fluid Correlate to Posture and Gait Difficulty in Parkinson's Disease

Citation


Disclaimer: This site does not employ and is not overseen by medical professionals. Content on Disabled World is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. See our Terms of Service for more information.

Reporting Errors: Disabled World is an independent website, your assistance in reporting outdated or inaccurate information is appreciated. If you find an error please let us know.